5.0       Legal Implications

5.1       There are no specific legal implications

6.0       Consultation and Responses

6.1      This report has been the subject of full consultation with Directorates and is agreed by Management Board

7.0      Conclusions and Recommendations

7.1       That the Executive

i.          notes the position on the Council’s Treasury Management activities during the third quarter of 2025/26.

ii.         refers this report to the Audit Committee for their consideration as part of the overall monitoring arrangements for Treasury Management.  

iii.        note the updated Q3 2025/26 Capital Plan.

iv.        approve the allocation of £175k of Strategic Capacity Reserve to deliver the pay-on-entry technology to 15 public convenience sites pending approval of proposals to be presented to Executive (paragraph 4.2).

v.         approve the extension to the repayment deadline for the existing Yorwaste loan to 27 March 2028 (paragraph 4.3).

vi.        approve the extension to the term for the existing Bracewell Homes loan to 31 March 2036 (paragraph 4.4).

vii.       notes the forecast outturn position against the 2025/26 Revenue Budget, as summarised in paragraph 2.2.1.

viii.      approves up to £3.6m over a three year period to fund a programme of Prevention Plus as set out in section 2.6 and delegates authority to the Corporate Director, Resources in consultation with the Corporate Director, HAS and the Executive Members for Finance and HAS to reframe the approach including the overall funding (up to a maximum of £3.6m over three years) in the event that NHS partners do not provide sufficient contribution to the overall funding.

Richard Flinton Chief Executive 17 February 2026

Gary Fielding Corporate Director, Strategic Resources